Apoptosis and oxidative stress in neurodegenerative diseases

Journal of Alzheimer's Disease

Volumn 42, Issue , 2014, Pages S125-S152

  Radi, Elena ^a   Formichi, Patrizia ^a   Battisti, Carla ^a   Federico, Antonio ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

Apoptosis; ATP13A2; CADASIL; caspases; neurodegeneration; Parkinson's disease; reactive oxygen species

Indexed keywords

ANTIOXIDANT; CYSTEINE PROTEINASE; FREE RADICAL; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; APOPTOSIS; CADASIL; CELL DEATH; CELL LOSS; CELL STRESS; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; CHROMATIN CONDENSATION; CONFERENCE PAPER; DEGENERATIVE DISEASE; DNA DAMAGE; DNA FRAGMENTATION; ENZYME ACTIVATION; HUMAN; HUNTINGTON CHOREA; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; MITOCHONDRION; MULTIPLE SCLEROSIS; NERVE CELL PLASTICITY; NERVE DEGENERATION; NITROSATIVE STRESS; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; REGULATORY MECHANISM; ANIMAL; BIOLOGICAL MODEL; DISEASE COURSE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; APOPTOSIS; DISEASE PROGRESSION; HUMANS; MODELS, BIOLOGICAL; NEURODEGENERATIVE DISEASES; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 84912571285     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-132738     Document Type: Conference Paper

References (243)

1. CohenGM(1997) Caspases: The executioners of apoptosis. Biochem J 326, 1-16.
2. Elmore S (2007) Apoptosis: A review of programmed cell death. Toxicol Pathol 35, 495-516.
3. Kannan K, Jain SK (2000) Oxidative stress and apoptosis. Pathophysiology 7, 153-163.
4. Lauber K, Blumenthal SG, Waibel M, Wesselborg S (2004) Clearance of apoptotic cells: Getting rid of the corpses. Mol Cell 14, 277-287.
5. Ravichandran KS (2011) Beginnings of a good apoptotic meal: The find-me and eat-me signaling pathways. Immunity 35, 445-455.
6. Fadeel B, Orrenius S (2005) Apoptosis: A basic biological phenomenon with wide-ranging implications in human disease. J Intern Med 258, 479-517.
7. McIlwain DR, Berger T, Mak TW(2013) Caspase functions in cell death and disease. Cold Spring Harb Perspect Biol 5, a008656.
8. Hengatner MO (2000) The biochemistry of apoptosis. Nature 407, 770-776.
9. Danial NN,Korsmeyer SJ (2004) Cell death: Critical control points. Cell 116, 205-219.
10. Brenner D, Mak TW(2009) Mitochondrial cell death effectors. Curr Opin Cell Biol 21, 871-877.
11. Saelens X, Festjens N, Vande Walle L, van Gurp M, van Loo G, Vandenabeele P (2004) Toxic proteins released from mitochondria in cell death. Oncogene 23, 2861-2874.
12. Barczyk K, Kreuter M, Pryjma J, Booy EP, Maddika S, Ghavami S, Berdel WE, Roth J, Los M (2005) Serum cytochrome c indicates in vivo apoptosis and can serve as a prognostic marker during cancer therapy. Int J Cancer 116, 167-173.
13. Cory S, Adams JM (2002) The Bcl2 family: Regulators of the cellular life-or-death switch. Nat Rev Cancer 2, 647-656.
14. Altieri DC (2010) Survivin and IAP proteins in cell-death mechanisms. Biochem J 430, 199-205.
15. WangX(2001) The expanding role of mitochondria in apoptosis. Genes Dev 15, 2922-2933.
16. Peter ME, Krammer PH (2003) The CD95(APO-1/Fas) DISC and beyond. Cell Death Differ 10, 26-35.
17. Munoz-Pinedo C (2012) Signaling pathways that regulate life and cell death: Evolution of apoptosis in the context of self-defense. Adv Exp Med Biol 738, 124-143.
18. Tait SW, Green DR (2010) Mitochondria and cell death: Outer membrane permeabilization and beyond. Nat Rev Mol Cell Biol 11, 621-632.
19. Orrenius S (2004) Mitochondrial regulation of apoptotic cell death. Toxicol Lett 149, 19-23.
20. Green D, Reed JC (1998) Mitochondria and apoptosis. Science 281, 1309-1312.
21. Orrenius S, Gogvadze V, Zhivotovsky B (2007) Mitochondrial oxidative stress: Implications for cell death. Annu Rev Pharmacol Toxicol 47, 143-183.
22. Sinha K, Das J, Pal PB, Sil PC (2013) Oxidative stress: The mitochondria-dependent and mitochondriaindependent pathways of apoptosis. Arch Toxicol 87, 1157-1180.
23. RaoRV, Castro-Obregon S, Frankowski H, Schuler M, Stoka V, del Rio G, Bredesen DE, Ellerby HM (2002) Coupling endoplasmic reticulum stress to the cell death program. An Apaf-1-independent intrinsic pathway. J Biol Chem 277, 21836-21842.
24. Slee EA, Adrain C, Martin SJ (2001) Executioner caspase-3,-6, and-7 perform distinct, non-redundant roles during the demolition phase of apoptosis. J Biol Chem 276, 7320-7326.
25. Chipuk JE, Green DR (2006) Dissecting p53-dependent apoptosis. Cell Death Differ 13, 994-1002.
26. Culmsee C, Mattson MP (2005) p53 in neuronal apoptosis. Biochem Biophys Res Commun 331, 761-777.
27. Levy OA, Malagelada C, Greene LA (2009) Cell death pathways in Parkinson's disease: Proximal triggers, distal effectors, and final steps. Apoptosis 14, 478-500.
28. Telford WG, King LE, Fraker PJ (1991) Evaluation of glucocorticoid-induced DNA fragmentation in mouse thymocytes by flow cytometry. Cell Prolif 24, 447-459.
29. Formichi P, Battisti C, Tripodi SA, Tosi P, Federico A (2000) Apoptotic response and cell cycle transition in ataxia telangiectasia cells exposed to oxidative stress. Life Sci 66, 1893-1903.
30. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C (1991) A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 139, 271-279.
31. Barbieri D, Grassilli E, Monti D, Salvioli S, Franceschi MG, Franchini A, Bellesia E, Salomoni P, Negro P, Troiano L, Cossarizza A, Franceschi C (1994) D-ribose and deoxy-D-ribose induce apoptosis in human quiescent peripheral blood mononuclear cells. Biochem Biophys Res Commun 201, 1109-1116.
32. Formichi P, Radi E, Battisti C, Tarquini E, Leonini A, Di Stefano A, Federico A (2006) Human fibroblasts undergo oxidative stress-induced apoptosis without internucleosomal DNA fragmentation. J Cell Physiol 208, 2892-2897.
33. Ito Y, Otsuki Y (1998) Localization of apoptotic cells in the human epidermis by an in situ DNA nick end-labeling method using confocal reflectant laser microscopy. J Histochem Cytochem 46, 783-786.
34. Ansari B, Coates PJ, Greenstein BD, Hall PA (1993) In situ endlabeling detects DNA strand breaks in apoptosis and other physiological and pathological states. J Pathol 170, 1-8.
35. Gurtu V, Kain SR, Zhang G (1997) Fluorometric and colorimetric detection of caspase activity associated with apoptosis. Anal Biochem 251, 98-102.
36. Grabarek J, Amstad P, Darzynkiewicz Z (2002) Use of fluorescently labeled caspase inhibitors as affinity labels to detect activated caspases. Hum Cell 15, 1-12.
37. Bossy-Wetzel E, Green DR (2000) Detection of apoptosis by Annexin V labeling. Methods Enzymol 322, 15-18.
38. Poot M, Pierce RH (1999) Detection of changes in mitochondrial function during apoptosis by simultaneous staining with multiple fluorescent dyes and correlated multiparameter flow cytometry. Cytometry 35, 311-317.
39. Lieven CJ, Vrabec JP, Levin LA (2003) The effects of oxidative stress on mitochondrial transmembrane potential in retinal ganglion cells. Antioxid Redox Signal 5, 641-646.
40. Finkel T (2011) Signal transduction by reactive oxygen species. J Cell Biol 194, 7-15.
41. Catala A (2011) Lipid peroxidation of membrane phospholipids in the vertebrate retina. Front Biosci (Schol ed) 3, 52-60.
42. Catala A (2012) Lipid peroxidation modifies the picture of membranes from the "Fluid Mosaic Model" to the "Lipid Whisker Model". Biochimie 94, 101-109.
43. Suemori S, Shimazawa M, Kawase K, Satoh M, Nagase H, Yamamoto T, Hara H (2006) Metallothionein, an endogenous antioxidant, protects against retinal neuron damage in mice. Invest Ophtalmol Vis Sci 47, 3975-3982.
44. Mates JA, Segura FJ, Alonso FJ, Marquez J (2010) Oxidative stress in apoptosis and cancer: An update. Arch Toxicol 86, 1648-1665.
45. Tsujimoto Y, Shimizu S (2007) Role of the mitochondrial membrane permeability transition in cell death. Apoptosis 12, 835-840.
46. Santamaria G, Martinez-Diez M, Fabregat I, Cuezva JM (2006) Efficient execution of cell death in non-glycolytic cells requires the generation of ROS controlled by the activity of mitochondrial H+-ATP synthase. Carcinogenesis 27, 925-935.
47. Circu M, Aw TY (2010) Reactive oxygen species, cellular redox systems, and apoptosis. Free Radic Biol Med 48, 749-762.
48. Chen Q, Lesnefsky EJ (2006) Depletion of cardiolipin and cytochrome c during ischemia increases hydrogen peroxide production from the electron transport chain. Free Radic Biol Med 40, 976-982.
49. Gonzalvez F, Pariselli F, Dupaigne P, Budihardjo I, Lutter M, Antonsson B, Diolez P, Manon S, Martinou JC, Goubern M,Wang X, Bernard S, Petit PX (2005) tBid interaction with cardiolipin primarily orchestrates mitochondrial dysfunctions and subsequently activates Bax and Bak. Cell Death Differ 12, 614-626.
50. Clayton DA (1984) Transcription of the mammalian mitochondrial genome. Annu Rev Biochem 53, 573-594.
51. Van Houten B, Woshner V, Santos JH (2006) Role of mitochondrial DNA in toxic responses to oxidative stress. DNA Repair (Amsterdam) 5, 145-152.
52. Grishko V, Pastukh V, Solodushko V, Gillespie M, Azuma J, Schaffer S (2003) Apoptotic cascade initiated by angiotensin II in neonatal cardiomyocytes: Role of NA damage. Am J Physiol Heart Circ Physiol 285, H2364-H2372.
53. Schmidt SP, Corydon TJ, Pedersen CB, Bross P, Gregersen N (2010) Misfolding of short-chain acyl-CoA dehydrogenase leads to mitochondrial fission and oxidative stress. Mol Genet Metab 100, 155-162.
54. Wu S, Zhou F, Zhang Z, Xing D (2011) Mitochondrial oxidative stress causes mitochondrial fragmentation via differential modulation of mitochondrial fission-fusion proteins. FEBS J 78, 941-954.
55. Bailey SM (2003) A review of the role of reactive oxygen and nitrogen species in alcohol-induced mitochondrial dysfunction. Free Radic Res 37, 585-596.
56. Ferrari LF, Chum A, Bogen O, Reichling DB, Levine JD (2011) Role of Drp1, a key mitochondrial fission protein, in neuropathic pain. J Neurosci 31, 11404-11410.
57. Jou MJ, Peng TI, Wu H, Wei Y (2005) Enhanced generation of mitochondrial reactive oxygen species in cybrids containing 4977-bp mitochondrial DNA deletion. Ann NY Acad Sci 1042, 221-228.
58. Feissner RF, Skalska J, Gaum WE, Sheu SS (2009) Crosstalk signaling between mitochondrial Ca2+ and ROS. Front Biosci 14, 1197-1218.
59. Lin MT, Beal MF (2006) Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443, 787-795.
60. Lipton SA (2006) Paradigm shift in neuroprotection by NMDA receptor blockade: Memantine and beyond. Nat Rev Drug Discov 5, 160-170.
61. Gu Z, Nakamura T, Lipton SA (2010) Redox reactions induced by nitrosative stress mediate protein misfolding and mitochondrial dysfunction in neurodegenerative diseases. Mol Neurobiol 41, 55-72.
62. Foster MW, Liu L, Zeng M, Hess DT, Stamler JS (2009) A genetic analysis of nitrosative stress. Biochemistry 48, 792-799.
63. Dahm CC, Moore K, Murphy MP (2006) Persistent Snitrosation of complex I and other mitochondrial membrane proteins by S-nitrosothiols but not nitric oxide or peroxynitrite: Implications for the interaction of nitric oxide with mitochondria. J Biol Chem 281, 10056-10065.
64. Kang-Decker N, Cao S, Chatterjee S, Yao J, Egan LJ, Semela D, Mukhopadhyay D, Shah V (2007) Nitric oxide promotes endothelial cell survival signaling through Snitrosylation and activation of dynamin-2. J Cell Sci 120, 492-501.
65. Cho DH, Nakamura T, Fang J, Cieplak P, Godzik A, Gu Z, Lipton SA. S-Nitrosylation of Drp1 mediates beta-amyloidrelated mitochondrial fission and neuronal injury. Science 324, 102-105.
66. Beckman JS, Koppenol WH (1996) Nitric oxide, superoxide, and peroxynitrite: The good, the bad, and ugly. Am J Physiol 271, C1424-C1437.
67. ChenW, Zhuang J, Li Y, Shen Y, Zheng X (2013) Myricitrin protects against peroxynitrite-mediated DNA damage and cytotoxicity in astrocytes. Food Chem 141, 927-933.
68. Komjati K, Besson VC, Szabo C (2005) Poly (adp-ribose) polymerase inhibitors as potential therapeutic agents in stroke and neurotrauma. Curr Drug Targets CNS Neurol Disord 4, 179-194.
69. Zhang K, Kaufman RJ (2006) The unfolded protein response: A stress signaling pathway critical for health and disease. Neurology 66, S102-S109.
70. Cocheme HM, Murphy MP (2010) Can antioxidants be effective therapeutics? Curr Opin Investig Drugs 11, 426-431.
71. Niki E (2012) Do antioxidants impair signaling by reactive oxygen species and lipid oxidation products? FEBS Lett 586, 3767-3770.
72. Halliwell B (2006) Oxidative stress and neurodegeneration: Where are we now? J Neurochem 97, 1634-1658.
73. Ramalingam M, Kim SJ (2012) Reactive oxygen/nitrogen species and their functional correlations in neurodegenerative diseases. J Neural Transm 119, 891-910.
74. Mattson MP (2000) Apoptosis in neurodegenerative disorders. Nat Rev Mol Cell Biol 1, 120-129.
75. Spillantini MG, GoedertM(1998) Tau protein pathology in neurodegenerative diseases. Trends Neurosci 21, 428-433.
76. Haas C, De Strooper B (1999) The presenilins in Alzheimer's disease-proteolysis holds the key. Science 286, 916-919.
77. Butterfield DA, Kanski J (2001) Brain protein oxidation in age-related neurodegenerative disorders that are associated with aggregated proteins. Mech Ageing Dev 122, 945-962.
78. Mattson MP, Duan W, Pedersen WA, Culmsee C (2001) Neurodegenerative disorders and ischemic brain diseases. Apoptosis 6, 69-81.
79. AnantharamanM, Tangpong J, Keller JN, Murphy MP, Markesbery WR, Kiningham KK, St Clair DK (2006) β-amyloid mediated nitration of manganese superoxide dismutase: Implication for oxidative stress in a APPNLh/NLh X PS-1 P264L/P264L double knock-in mouse model of Alzheimer's disease. Am J Pathol 168, 1608-1618.
80. Praticò D, Sung S (2004) Lipid peroxidation and oxidative imbalance: Early functional events in Alzheimer's disease. J Alzheimers Dis 6, 171-175.
81. Choi J, Levey AI, Weintraub ST, Rees HD, Gearing M, Chin LS, Li L (2004) Oxidative modifications and downregulation of ubiquitin carboxyl-terminal hydrolase L1 associated with idiopatic Parkinson's and Alzheimer's disease. J Biol Chem 279, 13256-13264.
82. Gamblin TC, King ME,Kuret J, BerryRW, Binder LI (2000) Oxidative regulation of fatty acid-induced tau polymerization Biochem 39, 14203-14210.
83. Nishida Y, Yokota T, Takahashi T, Uchihara T, Jishage KI, Mizusawa H (2006) Deletion of vitamin E enhances phenotype of Alzheimer disease model mouse. Biochem Biophys Res Commun 350, 530-536.
84. Ansari MA, Scheff SW (2010) Oxidative stress in the progression of Alzheimer disease in the frontal cortex. J Neuropathol Exp Neurol 69, 155-167.
85. Manczak M, Anekonda TS, Henson E, Park BS, Quinn J, Reddy PH (2006) Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: Implication for free radical generation and oxidative damage in disease progression. Hum Mol Genet 15, 1437-1449.
86. Zhao Y, Zhao B (2013) Oxidative stress and the pathogenesis of Alzheimer's disease. Oxid Med Cell Long 2013, 316523.
87. Butterfield DA, Boyd-Kimball D (2004) Amyloid betapeptide (1-42) contributes to the oxidative stress and neurodegeneration found in Alzheimer's disease. Brain Pathol 14, 426-432.
88. Rochet JC, Liu F (2009) Inhibition of alpha-synuclein aggregation by antioxidants and chaperones in Parkinson's disease. In Protein Folding and Misfolding: Neurodegenerative Diseases,Ovadi J, Orosz F, eds. Springer, Netherlands, pp. 175-206.
89. Arreguin S, Nelson P, Padway S, Shirazi M, Pierpont C (2009) Dopamine complexes of iron in the etiology and pathogenesis of Parkinson's disease. J Inorg Biochem 103, 87-93.
90. Gotz ME, Double K, Gerlach M, Youdim MBH, Riederer P (2004) The relevance of iron in the pathogenesis of Parkinson's disease. Ann NY Acad Sci 1012, 193-208.
91. Castellani RJ, Siedlak SL, Perry G, Smith MA (2000) Sequestration of iron by Lewy bodies in Parkinson's disease. Acta Neuropathol 100, 111-114.
92. Alam ZI, Daniel SE, Lees AJ, Marsden DC, Jenner P, Halliwell BA (1997) Generalised increase in protein carbonyls in the brain in Parkinson's but not incidental Lewy body disease. J Neurochem 69, 1326-1329.
93. Taylor JM, Main BS, Crack PJ (2013) Neuroinflammation and oxidative stress: Co-conspirators in the pathology of Parkinson's disease. Neurochem Int 62, 803-819.
94. Jellinger KA (2009) Recent advances in our understanding of neurodegeneration. J Neural Transm 116, 1111-1162.
95. Chung KK, Thomas B, Li X, Pletnikova O, Troncoso JC, Marsh L, Dawson VL, Dawson TM (2004) S-nitrosylation of parkin regulates ubiquitination and compromises parkin's protective function. Science 304, 1328-1331.
96. Choi J, Sullards MC, Olzmann JA, Rees HD,Weintraub ST, Bostwick DE, Gearing M, Levey AI, Chin LS, Li L (2006) Oxidative damage of DJ-1is linked to sporadic Parkinson and Alzheimer diseases. J Biol Chem 281, 10816-10824.
97. Weinreb O, Mandel S,Youdim MBH, Amit T (2013) Targeting dysregulation of brain iron homeostasis in Parkinson's disease by iron chelators. Free Radic Biol Med 62, 52-64.
98. Jenner P (2007) Oxidative stress and Parkinson's disease. Handb Clin Neurol 83, 507-520.
99. Ayala-Pena S (2013) Role of oxidative DNA damage in mitochondrial dysfunction and Huntington's disease pathogenesis. Free Radic Biol Med 62, 102-110.
100. Browne SE, Beal MF (2006) Oxidative damage in Huntington's disease pathogenesis. Antioxid Redox Signal 8, 2061-2073.
101. Hands S, Sajjad M, Newton M, Wyttenbach A (2011) In vitro and in vivo aggregation of a fragment of huntingtin protein directly causes free radical production. J Biol Chem 286, 44512-44520.
102. Siddiqui A, Rivera-Sanchez S, Castro MDR, Rane A, Acevedo-Torres K, Torres-Ramos C, Nicholls D, Andersen J, Ayala-Torres S (2012) Mitochondrial DNA damage is associated with reduced mitochondrial bioenergetics in Huntington's disease. Free Radic Biol Med 53, 1478-1488.
103. St-Pierre J, Drori S, Uldry M, Silvaggi JM, Rhee J, Jager S, Handschin C, Zheng K, Lin J, Yang W, Simon DK, Bachoo R, Spiegelman BM (2006) Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell 127, 397-408.
104. del Hoyo P, Garcia-Redondo A, de Bustos F, Molina JA, Sayed Y, Alonso-Navarro H, Caballero L, Arenas J, Jimenez-Jimenez FJ (2006) Oxidative stress in skin fibroblasts cultures of patients with Huntington's disease. Neurochem Res 31, 1103-1109.
105. Browne SE, Ferrante RJ, Beal MF (1999) Oxidative stress in Huntington's disease. Brain Pathol 9, 147-163.
106. Tabrizi SJ, Cleeter MW, Xuereb J, Taanman JW, Cooper JM, Schapira AH (1999) Biochemical abnormalities and excitotoxicity in Huntington's disease brain. Ann Neurol 45, 25-32.
107. Duffy LM, Chapman AL, Shaw PJ, Grierson AJ (2011) Review: The role of mitochondria in the pathogenesis of amyotrophic lateral sclerosis. Neuropathol Appl Neurobiol 37, 336-352.
108. Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, Donaldson D, Goto J, O'Regan JP, Deng HX, Rahmani O, Krizus A, Mckenna-Yasek D, Cayabyab A, Gaston SM, Berger R, Tanzi RE, Halperin JJ, Herzfeldt B, Van Den Bergh R, Hung WY, Bird T, Deng G, Mulder DW, Smyth C, Laing NG, Soriano E, Pericak-Vance MA, Haines J, Rouleau GA, Gusella JS, Horvitz HR, BrownRHJr (1993) Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362, 59-62.
109. McCord JM, Fridovich I (1969) Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J Biol Chem 244, 6049-6055.
110. Turner MR, Bowser R, Bruijn L, Dupuis L, Ludolph A, Mcgrath M, Manfredi G, Maragakis N, Miller RG, Pullman SL, Rutkove SB, Shaw PJ, Shefner J, Fischbeck KH (2013) Mechanisms, models and biomarkers in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener 14, 19-32.
111. Tohgi H, Abe T, Yamazaki K, Murata T, Ishizaki E, Isobe C (1999) Increase in oxidized NO products and reduction in oxidized glutathione in cerebrospinal fluid from patients with sporadic forms of amyotrophic lateral sclerosis. Neurosci Lett 260, 204-206.
112. Chang Y, Kong Q, Shan X, Tian G, Ilieva H, Cleveland DW, Rothstein JD, Borchelt DR, Wong PC, Lin CL (2008) Messenger RNA oxidation occurs early in disease pathogenesis and promotes motor neuron degeneration in ALS. PLoS One 3, e2849.
113. Barber SC, Shaw PJ (2010) Oxidative stress in ALS: Key role in motor neuron injury and therapeutic target. Free Radic Biol Med 48, 629-641.
114. Rakhit R, Crow JP, Lepock JR, Kondejewski LH, Cashman NR, Chakrabartty A (2004) Monomeric Cu, Zn-superoxide dismutase is a common misfolding intermediate in the oxidation models of sporadic and familial amyotrophic lateral sclerosis. J Biol Chem 279, 15499-15504.
115. Vijayverguya C, Beal MF, Buck J, Manfredi G (2005) Mutant superoxide dismutase 1 forms aggregates in the brain mitochondrial matrix of amyotrophic lateral sclerosis mice. J Neurosci 25, 2463-2470.
116. Henkel JS, Engelhardt JI, Siklos L, Simpson EP, Kim SH, Pan T, Goodman JC, Siddique T, Beers DR, Appel SH (2004) Presence of dendritic cells, MCP-1, and activated microglia/macrophages in amyotrophic lateral sclerosis spinal cord tissue. Ann Neurol 55, 221-235.
117. Rao SD, Yin HZ,Weiss JH (2003) Disruption of glial glutamate transport by reactive oxygen species produced in motor neurons. J Neurosci 23, 2627-2633.
118. Clement AM, Nguyen MD, Roberts EA, Garcia ML, Boilleé S, Rule M, McMahon AP, Doucette W, Siwek D, Ferrante RJ, Brown RH Jr, Julien JP, Goldstein LSB, Cleveland DW (2003) Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science 302, 113-117.
119. Yamanaka K, Boillee S, Roberts EA, Garcia ML,McAlonis-Downes M, Mikse OR, Cleveland DW, Goldstein LS (2008) Mutant SOD1 in cell types other than motor neurons and oligodendrocytes accelerates onset of disease in ALS mice. Proc Natl Acad Sci USA 105, 7594-7599.
120. Abe K, Pan LH, Watanabe M, Konno H, Kato T, Itoyama Y (1997) Upregulation of protein-tyrosine nitration in the anterior horn cells of amyotrophic lateral sclerosis. Neurol Res 19, 124-128.
121. Beckman JS, Carson M, Smith CD, Koppenol WH (1993) ALS, SOD and peroxynitrite. Nature 364, 584.
122. Olmez I, Ozyurt H (2012) Reactive oxygen species and ischemic cerebrovascular disease. Neurochem Int 60, 208-212.
123. Chen H, Yoshioka H, Kim GS, Jung JE, Okami N, Sakata H, Maier CM, Narasimhan P, Goeders CE, Chan PH (2011) Oxidative stress in ischemic brain damage: Mechanisms of cell death and potential molecular targets forneuroprotection. Antioxid Redox Signal 14, 1505-1517.
124. Kaur J, Arora S, Singh B, Thakur LC, Gambhir J, Prabhu KM (2011) Role of oxidative stress in pathophysiology of transient ischemic attack and stroke. Int J Biol Med Res 2, 611-615.
125. Manzanero S, Santro T, Arumugam TV (2013) Neuronal oxidative stress in acute ischemic stroke: Sources and contribution to cell injury. Neurochem Int 62, 712-718.
126. Mergenthaler P, Dirnagl U, Meisel A (2004) Pathophysiology of stroke: Lessons from animal models. Metab Brain Dis 19, 151-167.
127. Chen Q, Moghaddas S, Hoppel CL, Lesnefsky EJ (2008) Ischemic defects in the electron transport chain increase the production of reactive oxygen species from isolated rat heart mitochondria. Am J Physiol Cell Physiol 294, C460-C466.
128. Kushnareva Y, Murphy AN, Andreyev A (2002) Complex I-mediated reactive oxygen species generation: Modulation by cytochrome c and NAD(P) + oxidation-reduction state. Biochem J 368, 545-553.
129. Trinei M, Giorgio M, Cicalese A, Barozzi S, Ventura A, Migliaccio E, Milia E, Padura IM, Raker VA, Maccarana M, Petronilli V, Minucci S, Bernardi P, Lanfrancone L, Pelicci PG (2002) A p53-p66Shc signalling pathway controls intracellular redox status, levels of oxidation-damaged DNA and oxidative stress-induced apoptosis. Oncogene 21, 3872-3878.
130. Cave AC, Brewer AC, Narayanapanicker A, Ray R, Grieve DJ, Walker S, Shah AM (2006) NADPH oxidases in cardiovascular health and disease. Antioxid Redox Signal 8, 691-728.
131. Pradeep H, Diya JB, Shashikumar S, Rajanikant GK (2012) Oxidative stress-assassin behind the ischemic stroke. Folia Neuropathol 50, 219-230.
132. Armitage ME,Wingler K, Schmidt HH, LaM(2009) Translating the oxidative stress hypothesis into the clinic: NOX versus NOS. J Mol Med 87, 1071-1076.
133. Forsterman U (2008) Oxidative stress in vascular disease: Causes, defense mechanisms and potential therapies. Nat Clin Pact Cardiovasc Med 5, 338-349.
134. Ichim G, Tauszig-Delamasure S, Mehlen P (2012) Neurotrophins and cell death. Exp Cell Res 318, 1221-1228.
135. Putcha GV, Deshmukh M, Johnson EM Jr (1999) BAX translocation is a critical event in neuronal apoptosis: Regulation by neuroprotectants, BCL-2, and caspases. J Neurosci 19, 7476-7485.
136. Segal RA, Greenberg ME (1996) Intracellular signaling pathways activated by neurotrophic factors. Annu Rev Neurosci 19, 463-489.
137. Orike N, Middleton G, Borthwick E, Buchman V, Cowen T, Davies AM (2001) Role of PI 3-kinase, Akt and Bcl-2-related proteins in sustaining the survival of neurotrophic factor-independent adult sympathetic neurons. J Cell Biol 154, 995-1005.
138. Ganel R, Rothstein JD (1999) Glutamate transporter dysfunction and neuronal death. In: Ionotropic glutamate receptors in the CNS, Hannah M, Adelmann GA, Peter J, eds. Springer. Berlin, pp. 472-493.
139. Wang Y, Qin ZH (2010) Molecular and cellular mechanisms of excitotoxic neuronal death. Apoptosis 15, 1382-1402.
140. Kim K, Lee SG, Kegelman TP, Su ZZ, Das SK, Dash R, Dasgupta S, Barral PM, Hedvat M, Diaz P, Reed JC, Stebbins JL, Pellecchia M, Sarkar D, Fisher PB (2011) Role of excitatory amino acid transporter-2 (EAAT2) and glutamate in neurodegeneration: Opportunities for developing novel therapeutics. J Cell Physiol 226, 2484-2493.
141. Chan SL, Mattson MP(1999) Caspase and calpain substrates roles in synaptic plasticity and cell death. J Neurosci Res 58, 167-190.
142. Mattson MP, Duan W, Chan SL, Camandola S (1999) Par-4: An emerging pivoltal player in neuronal apoptosis and neurodegenerative disorders. J Mol Neurosci 13, 17-30.
143. Liu JP (1999) Studies of the molecular mechanisms in the regulation of telomerase activity. FASEB J 13, 17-30.
144. FuW, Killen M, Pandita T, Mattson MP (2000) the catalytic subunit of telomerase is expressed in developing brain neurons and serves a cell survival promoting function. J Mol Neurosci 14, 3-15.
145. Zorzano A, Liesa M, Sebastian D, Segales J, Palacin M (2010) Mitochondrial fusion proteins: Dual regulators of morphology and metabolism. Semin Cell Dev Biol 21, 566-574.
146. Reddy PH, Reddy TP, Manczak M, Calkins MJ, Shirendeb U, Mao P (2011) Dynamin-related protein 1 and mitochondrial fragmentation in neurodegenerative diseases. Brain Res Rev 67, 103-118.
147. Wasiak S, Zunino R, McBride HM (2007) Bax/Bak promote sumoylation of DRP1 and its stable association with mitochondria during apoptotic cell death. J Cell Biol 177, 439-450.
148. Frezza C, Cipolat S, Martins de Brito O, Micaroni M, Beznoussenko GV, Rudka T, Bartoll D, Pollshuck RS, Danial NN, De Strooper B, Scorrano L (2006) Opa1 controls apoptotic cristae remodeling independently from mitochondrial fusion. Cell 126, 177-189.
149. Wang X, Su B, Lee HG, Li X, Perry G, Zhu X (2009) Impaired balance of mitochondrial fission and fusion in Alzheimer's disease. J Neurosci 29, 9090-9103.
150. Manczak M, Calkins MJ, Reddy PH (2011) Impaired mitochondrial dynamics and abnormal interaction of amyloid beta with mitochondrial protein Drp1 in neurons from patients with Alzheimer's disease: Implications for neuronal damage. Hum Mol Genet 20, 2495-2509.
151. Itoh K, Nakamura K, Iijima M, Sesaki H (2013) Mitochondrial dynamics in neurodegeneration. Trends Cell Biol 23, 64-71.
152. Bossy-Wetzel E, Petrilli A, Knott AB (2008) Mutant huntingtin and mitochondrial dysfunction. Trends Neurosci 31, 609-616.
153. Panov AV, Gutekunst CA, Leavitt BR, Hayden MR, Burke JR, Strittmatter WJ, Greenamyre JT (2002) Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines. Nat Neurosci 5, 731-736.
154. Li Z, Sheng M (2012) Caspase in synaptic plasticity. Mol Brain 5, 15-20.
155. Kessels HW, Malinow R (2009) Synaptic AMPA receptor plasticity and behaviour. Neuron 61, 340-350.
156. Jiao S, Li Z (2011) Nonapoptotic function of BAD and BAX in long-term depression of synaptic transmission. Neuron 70, 758-772.
157. Arendt T (2009) Synaptic degeneration in Alzheimer's disease. Acta Neuropathol 118, 167-179.
158. Snighda S, Smith ED, Prieto GA, Cotman CW (2012) Caspase 3 activation as a bifurcation point between plasticity and cell death. Neurosci Bull 28, 14-24.
159. Davydov V, Hansen LA, Shackelford DA (2003) Is DNA repair compromised in Alzheimer's disease? Neurobiol Aging 24, 953-968.
160. Lassman H, Bancher C, Breitschopf H, Weigel J, Bobinski M, Jellinger K, Wisniewski HM (1995) Cell death in Alzheimer's disease evaluate by DNA fragmentation in situ. Acta Neuropathol 89, 35-41.
161. Woodhouse A, Dickson TC,West AK, McLean CA,Vickers JC (2006) No difference in expression of apoptosis-related proteins and apoptotic morphology in control, pathologically aged and Alzheimer's disease cases. Neurobiol Dis 22, 323-333.
162. Gharibyan AL, Zamotin V, Yanamandra K, Moskaleva OS, Margulis BA, Kostanyan IA, Morozova-Roche LA (2007) Lysozyme amyloid oligomers and fibrils induce cellular death via different apoptotic/necrotic pathways. J Mol Biol 365, 1337-1349.
163. Lin W, Ming Ding M, Xue J, Leng W (2013) The role of TLR2/JNK/NF-B pathway in amyloid-peptide-induced inflammatory response in mouse NG108-15 neural cells. Int Immunopharmacol 17, 880-884.
164. Nicolaev A, McLaughlin T, O'Leary D, Tessier-Lavigne M (2009) N-APP binds DR6 to cause axon pruning and neuron death via distinct caspases. Nature 457, 981-989.
165. Schoenmann Z, Assa-Kunik E, Tiomny S,Minis A, Haklai-Topper L, Arama E, Yaron A (2010) Axonal degeneration is regulated by the apoptotic machinery or a NAD+-sensitive pathway in insects and mammals. J Neurosci 30, 6375-6386.
166. Monnier PP, D'Onofrio PM, Magharious M, Hollander AC, Tassew N, Szydlowska K, Tymianski M, Koeberle PD (2011) Involvement of caspase-6 and caspase-8 in neuronal apoptosis and the regenerative failure of injured retinal ganglion cells. J Neurosci 31, 10494-10505.
167. Cowling V, Downward J (2002) Caspase-6 is the direct activator of caspase-8 in the cytochrome c-induced apoptosis pathway: Absolute requirement for removal of caspase-6 prodomain. Cell Death Differ 9, 1046-1056.
168. Allsopp TE, McLuckie J, Kerr LE, Macleod M, Sharkey J, Kelly JS (2000) Caspase 6 activity initiates caspase 3 activation in cerebellar granule cell apoptosis. Cell Death Differ 7, 984-993.
169. Rouaux C, Loeffler JP, Boutillier AL (2004) Targeting CREB-binding protein (CBP) loss of function as a therapeutic strategy in neurological disorders. Biochem Pharmacol 68, 1157-1164.
170. Levkau B, Scatena M, Giachelli CM, Ross R, Raines EW (1999) Apoptosis overrides survival signals through a caspase-mediated dominant-negative NF-kappa B loop. Nat Cell Biol 1, 227-233.
171. Hirsch EC, Hunot S, Faucheux B, Agid Y, Mizuno Y, Mochizuki H, Tatton WG, Tatton N, Olanow WC (1999) Dopaminergic neurons degenerate by apoptosis in Parkinson's disease. Mov Disord 14, 383-385.
172. Vila M, Przedborki S (2003) Targeting programmed cell death in neurodegenerative disease. Nat Rev Neurosci 4, 365-375.
173. Anglade P, Vyas S, Javoy-Agid F, Herrero MT, Michel PP, Marquez J, Mouatt-Prigent A, Ruberg M, Hirsch EC, Agid Y (1997) Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease. Histol Histopathol 12, 25-31.
174. Hartmann A, Hunot S, Michel PP, Muriel MP, Vyas S, Faucheux BA, Mouatt-Prigent A, Turmel H, Srinivasan A, Ruberg M, Evan GI, Agid Y, Hirsch EC (2000) Caspase-3: A vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease. Proc Natl Acad Sci USA 97, 2875-2880.
175. Hunot S, Vila M, Teismann P, Davis RJ, Hirsch EC, Przedborski S, Rakic P, Flavell RA (2004) JNK-mediated induction of cyclooxygenase 2 is required for neurodegeneration in a mouse model of Parkinson's disease. Proc Natl Acad Sci USA 101, 665-670.
176. Cha G-H, Kim S, Park J, Lee E, Kim M, Lee SB, Kim JM, Chung J, Cho KS (2005) Parkin negatively regulates JNK pathway in the dopaminergic neurons of Drosophila. Proc Natl Acad Sci USA 102, 10345-10350.
177. Perier C, Bove J, Wu DC, Dehay B, Choi DK, Jackson-Lewis V, Rathke-Hartlieb S, Bouillet P, Strasser A, Schulz JB, Przedborski S, Vila M (2007) Two molecular pathways initiate mitochondria-dependent dopaminergic neurodegeneration in experimental Parkinson's disease. Proc Natl Acad Sci USA 104, 8161-8166.
178. Duan W, Zhu X, Ladenheim B, Yu QS, Guo Z, Oyler J, Cutler RG, Cadet JL, Greig NH, Mattson MP (2002) p53 inhibitors preserve dopamine neurons and motor function in experimental parkinsonism. Ann Neurol 52, 597-606.
179. Steckley D, Karajgikar M, Dale LB, Fuerth B, Swan P, Drummond-Main C, Poulter MO, Ferguson SS, Strasser A, Cregan SP (2007) Puma is a dominant regulator of oxidative stress induced Bax activation and neuronal apoptosis. J Neurosci 27, 12989-12999.
180. Gomez-Lazaro M, Galindo MF, Concannon CG, Segura MF, Fernandez-Gomez FJ, Llecha N, Comella JX, Prehn JH, Jordan J (2008) 6-Hydroxydopamine activates the mitochondrial apoptosis pathway through p38 MAPK-mediated, p53-independent activation of Bax and PUMA. J Neurochem 104, 1599-1612.
181. Jellinger KA (2000) Cell death mechanisms in Parkinson's disease. J Neural Transm 107, 1-29.
182. Tatton NA (2000) Increased caspase 3 and Bax immunoreactivity accompany nuclear GAPDH translocation and neuronal apoptosis in Parkinson's disease. Exp Neurol 166, 29-43.
183. Horowitz JM, Pastor DM, Goyal A, Kar S, Ramdeen N, Hallas BH, Torres G (2003) BAX proteinimmunoreactivity in midbrain neurons of Parkinson's disease patients. Brain Res Bull 62, 55-61.
184. Hartmann A, Troadec J-D, Hunot S, Kikly K, Faucheux BA, Mouatt-Prigent A, Ruberg M, Agid Y, Hirsch EC (2001) Caspase-8 Is an effector in apoptotic death of dopaminergic neurons in Parkinson's disease, but pathway inhibition results in neuronal necrosis. J Neurosci 21, 2247-2255.
185. Mogi M, Kondo T, Mizuno Y, Nagatsu T (2007) p53 protein, interferon-gamma, and NF-kappaB levels are elevated in the parkinsonian brain. Neurosci Lett 414, 94-97.
186. Nair VD, McNaught KSP, Gonzalez-Maeso J, Sealfon SC, Olanow CW (2006) p53 mediates nontranscriptional cell death in dopaminergic cells in response to proteasome inhibition. J Biol Chem 281, 39550-39560.
187. Tanaka Y, Engelender S, Igarashi S, Rao RK, Wanner T, Tanzi RE, Sawa A, Dawson L, Dawson V, Ross TM, CA (2001) Inducible expression of mutant alpha-synuclein decreases proteasome activity and increases sensitivity to mitochondria-dependent apoptosis. Hum Mol Genet 10, 919-926.
188. Uversky VN (2007) Neuropathology, biochemistry, and biophysics of alpha-synuclein aggregation. J Neurochem 103, 17-37.
189. Seo JH, Rah JC, Choi SH, Shin JK, Min K, Kim HS, Park CH, Kim S, Kim EM, Lee SH, Lee S, Suh SW, Suh YH (2002) β-synuclein regulates neuronal survival via Bcl-2 family expression and PI3/Akt kinase pathway. FASEB J 16, 1826-1828.
190. Machida Y, Chiba T, Takayanagi A, Tanaka Y, Asanuma M, Ogawa N, Koyama A, Iwatsubo T, Ito S, Jansen PH, Shimizu N, Tanaka K, Mizuno Y, Hattori N (2005) Common anti-apoptotic roles of parkin and asynuclein in human dopaminergic cells. Biochem Biophys Res Commun 332, 233-240.
191. Yamada M, Iwatsubo T, Mizuno Y, Mochizuki H (2004) Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: Resemblance to pathogenetic changes in Parkinson's disease. J Neurochem 91, 451-461.
192. Flower TR, Chesnokova LS, Froelich CA, Dixon C, Witt SN (2005) Heat shock prevents alpha-synuclein-induced apoptosis in a yeast model of Parkinson's disease. J Mol Biol 351, 1081-1100.
193. Battisti C, Formichi P, Radi E, FedericoA(2008) Oxidativestress-induced apoptosis in PBLs of two patients with Parkinson disease secondary to alpha-synuclein mutation. J Neurol Sci 267, 120-124.
194. Darios F, Corti O, Lucking CB, Hampe C, Muriel MP, Abbas N, Gu WJ, Hirsch EC, Rooney T, Ruberg M, Brice A (2003) Parkin prevents mitochondrial swelling and cytochrome c release in mitochondria-dependent cell death. Hum Mol Genet 12, 517-526.
195. Palacino JJ, Sagi D, Goldberg MS, Krauss S, Motz C, Wacker M, Klose J, Shen J (2004) Mitochondrial dysfunction and oxidative damage in parkin-deficient mice. J Biol Chem 279, 18614-18622.
196. Pesah Y, Pham T, Burgess H, Middlebrooks B, Verstreken P, Zhou Y, Harding M, Bellen H, Mardon G (2004) Drosophila parkin mutants have decreased mass and cell size and increased sensitivity to oxygen radical stress. Development 131, 2183-2194.
197. Muftuoglu M, Elibol B, Dalmizrak O, Ercan A, Kulaksiz G, Ogus H, Dalkara T, Ozer N (2004) Mitochondrial complex I and IV activities in leukocytes from patients with parkin mutations. Mov Disord 19, 544-548.
198. Silvestri L, Caputo V, Bellacchio E, Atorino L, Dallapiccola B, Valente EM, Casari G (2005) Mitochondrial import and enzymatic activity of PINK1 mutants associated to recessive parkinsonism. Hum Mol Genet 14, 3477-3492.
199. Chen H, Chan DC (2009) Mitochondrial dynamics-fusion, fission, movement, and mitophagy-in neurodegenerative diseases. Hum Mol Genet 18, 169-176.
200. Deng H, Dodson MW, Huang H, Guo M(2008) The Parkinson's disease genes pink1 and parkin promote mitochondrial fission and/or inhibit fusion in Drosophila. Proc Natl Acad Sci USA 105, 14503-14508.
201. Yang Y, Gehrke S, Haque ME, Imai Y, Kosek J, Yang L, Beal MF, Nishimura I, Wakamatsu K, Ito S, Takahashi R, LuB(2005) Inactivation of Drosophila DJ-1 leads to impairments of oxidative stress response and phosphatidylinositol 3-kinase/Akt signaling. Proc Natl Acad Sci USA 102, 13670-13675.
202. Irrcher I, Aleyasin H, Seifert EL, Hewitt SJ, Chhabra S, Phillips M, Lutz AK, Rousseaux MW, Bevilacqua L, Jahani-Asl A, Callaghan S, MacLaurin JG, Winklhofer KF, Rizzu P, Rippstein P, Kim RH, Chen CX, Fon EA, Slack RS, Harper ME, McBride HM, Mak TW, Park DS (2010) Loss of the Parkinson's disease-linked gene DJ-1 perturbs mitochondrial dynamics. Hum Mol Genet 19, 3734-3746.
203. Thomas B, Beal MF (2007) Parkinson's disease. Hum Mol Genet 2, R183-R194.
204. Strauss KM, Martins LM, Plun-Favreau H, Marx FP, Kautzmann S, Berg D, Gasser T, Wszolek Z, Muller T, Bornemann A, Wolburg H, Downward J, Riess O, Schulz JB, Kruger R (2005) Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease. Hum Mol Genet 14, 2099-2111.
205. Radi E, Formichi P, Di Maio G, Battisti C, Federico A (2012) Altered apoptosis regulation in Kufor-Rakeb syndrome patients with mutations in the ATP13A2 gene. J Cell Mol Med 16, 1916-1923.
206. Tan J, Zhang T, Jiang L, Chi J, Hu D, Pan Q, Wang D, Zhang Z (2011) Regulation of intracellular manganese homeostasis byKufor-Rakeb syndrome-associatedATP13A2 protein. J Biol Chem 286, 29654-29662.
207. Oikawa S, Hirosawa I, Tada-Oikawa S, Furukawa A, Nishiura K, Kawanishi S (2006) Mechanism for manganese enhancement of dopamine-induced oxidative DNA damage and neuronal cell death. Free Radic Biol Med 41, 748-756.
208. Chen CJ, Liao SL (2002) Oxidative stress involves in astrocytic alterations induced by manganese. Exp Neurol 175, 216-225.
209. Kwik-Uribe CL, Reaney S, Zhu Z, Smith D (2003) Alterations in cellular IRP-dependent iron regulation by in vitro manganese exposure in undifferentiated PC12 cells. Brain Res 973, 1-15.
210. Gavin CE, Gunter KK, Gunter TE (1990) Manganese and calcium efflux kinetics in brain mitochondria. Relevance to manganese toxicity. Biochem J 266, 329-334.
211. Tamm C, Sabri F, Ceccatelli S (2008) Mitochondrialmediated apoptosis in neural stem cells exposed to manganese. Toxicol Sci 101, 310-320.
212. Graham RK, Deng Y, Carroll J, Vaid K, Cowan C, Pouladi MA, Metzler M, Bissada N, Wang L, Faull RL, Gray M, Yang XW, Raymond LA, Hayden MR (2010) Cleavage at the 586 amino acid caspase-6 site in mutant huntingtin influences caspase-6 activation in vivo. J Neurosci 30, 15019-15029.
213. Wellington CL, Ellerby LM, Gutekunst CA, Rogers D, Warby S, Graham RK, Loubser O, van Raamsdonk J, Singaraja R, Yang YZ, Gafni J, Bredesen D, Hersch SM, Leavitt BR, Roy S, Nicholson DW, Hayden MR (2002) Caspase cleavage of mutant huntingtin precedes neurodegeneration in Huntington's disease. J Neurosci 22, 7862-7872.
214. Akpan N, Serrano-Saiz E, Zacharia BE, Otten ML, Ducruet AF, Snipas SJ, LiuW,Velloza J, Cohen G, Sosunov SA, Frey WH 2nd, Salvesen GS, Connolly ES Jr, Troy CM (2011) Intranasal delivery of caspase-9 inhibitor reduces caspase-6-dependent axon/neuron loss and improves neurological function after stroke. J Neurosci 31, 8894-8904.
215. Sawa A, Wiegand GW, Cooper J, Margolis RL, Sharp AH, Lawler JF, Greenamyre JT Jr, Snyder SH, Ross CA (1999) Increased apoptosis of Huntington disease lymphoblasts associated with repeat length-dependent mitochondrial depolarization. Nat Med 5, 1194-1198.
216. Martin LJ, Al-Abdulla NA, Brambrink AM, Kirsch JR, Sieber FE, Portera-Cailliau C (1998) Neurodegeneration in excitotoxicity, global cerebral ischemia, and target deprivation: A perspective on the contributions of apoptosis and necrosis. Brain Res Bull 46, 281-309.
217. Martin LJ, Liu Z (2004) Opportunities for neuroprotection in ALS using cell death mechanism rationales. Drug Discov Today 1, 135-143.
218. Pasinelli P, Belford ME, Lennon N, Bacskai BJ, Hyman BT, Trotti D, Brown RH Jr (2004) Amyotrophic lateral sclerosis-associated SOD1 mutant proteins bind and aggregate with Bcl-2 in spinal cord mitochondria. Neuron 43, 19-30.
219. Kostic V, Jackson-Lewis V, de Bilbao F, Dubois-Dauphin M, Przedborski S (1997) Bcl-2: Prolonging life in a transgenic mouse model of familial amyotrophic lateral sclerosis. Science 277, 559-562.
220. Gould TW, Buss RR, Vinsant S, Prevette D, Sun W, Knudson CM, Milligan CE, Oppenheim RW (2006) Complete dissociation of motor neuron death from motor dysfunction by Bax deletion in a mouse model of ALS. J Neurosci 26, 8774-8786.
221. Jaarsma D, Rognoni F, van Duijn W, Verspaget HW, Haasdijk ED, Holstege JC (2001) CuZn superoxide dismutase (SOD1) accumulates in vacuolated mitochondria in transgenic mice expressing amyotrophic lateral sclerosis-linked SOD1 mutations. Acta Neuropathol 102, 293-305.
222. Mattiazzi M, D'Aurelio M, Gajewski CD, Martushova K, Kiaei M, Beal MF, Manfredi G (2002) Mutated human SOD1 causes dysfunction of oxidative phosphorylation in mitochondria of transgenic mice. J Biol Chem 277, 29626-29633.
223. Takeuchi H, Kobayashi Y, Ishigaki S, Doyu M, Sobue G (2002) Mitochondrial localization of mutant superoxide dismutase 1 triggers caspase-dependent cell death in a cellular model of familial amyotrophic lateral sclerosis. J Biol Chem 277, 50966-50972.
224. Akpan N, Troy CM (2013) Caspase inhibitors: Prospective therapies for stroke. Neuroscientist 19, 129-136.
225. Saito A, Hayashi T, Okuno S, Nishi T, Chan PH (2005) Modulation of p53 degradation via MDM2-mediated ubiquitylation and the ubiquitin-proteasome system during reperfusion after stroke: Role of oxidative stress. J Cereb Blood Flow Metab 25, 267-280.
226. Hong LZ, Zhao XY, Zhang HL (2010) p53-mediated neuronal cell death in ischemic brain injury. Neurosci Bull 26, 232-240.
227. Gomez-Sanchez JC, Delgado-Esteban M, Rodriguez-Hernandez I, Sobrino T, Perez de la Ossa N, Reverte S, Bolanos JP, Gonzalez-Sarmiento R, Castillo J, Almeida A (2011) The human Tp53 Arg72Pro polymorphism explains different functional prognosis in stroke. J Exp Med 208, 429-437.
228. Almeida A (2013) Genetic determinant of neuronal vulnerability to apoptosis. Cell Mol Life Sci 70, 71-88.
229. Cao G, Luo Y, Nagayama T, PeiW, Stetler RA, Graham SH, Chen J (2002) Cloning and characterization of rat caspase-9: Implications for a role in mediating caspase-3 activation and hippocampal cell death after transient cerebral ischemia. J Cereb Blood Flow Metab 22, 534-546.
230. Zhang H, Li Q, Li Q, Mei Y, GuoY (2008) The protection of Bcl-2 overexpression on rat cortical neuronal injury caused by analogous ischemia/reperfusion in vitro. Neurosci Res 62, 140-146.
231. Harrison DC, Davis RP, Bond BC, Campbell CA, JamesMF, Parsons AA, Philpott KL (2001) Caspasem RNA expression in a rat model of focal cerebral ischemia. Brain Res Mol Brain Res 89, 133-146.
232. Sugawara T, Lewen A, Gasche Y, Yu F, Chan PH (2002) Overexpression of SOD1 protects vulnerable motor neurons after spinal cord injury by attenuating mitochondrial cytochrome c release. FASEB J 16, 1997-1999.
233. Le DA,Wu Y, Huang Z, Matsushita K, Plesnila N, Augustinack JC, Hyman BT, Yuan J, Kuida K, Flavell RA, Moskowitz MA (2002) Caspase activation and neuroprotection in caspase-3-deficient mice after in vivo cerebral ischemia and in vitro oxygen glucose deprivation. Proc Natl Acad Sci USA 99, 15188-15193.
234. Mouw G, Zechel JL, Zhou Y, Lust WD, Selman WR, Ratcheson RA (2002) Caspase-9 inhibition after focal cerebral ischemia improves outcome following reversible focal ischemia. Metab Brain Dis 17, 143-151.
235. Chabriat H, Tournier-Lasserve E, Vahedi K, Leys D, Joutel A, Nibbio A, Escaillas JP, Iba-Zizen MT, Bracard S, Tehindrazanarivelo A (1995) Autosomal dominant migraine with MRI white-matter abnormalities mapping to the CADASIL locus. Neurology 45, 1086-1091.
236. Kalimo H, Ruchoux MM, Viitanen M, Kalaria RJ (2002) CADASIL:Acommon form of hereditary arteriopathy causing brain infarcts and dementia. Brain Pathol 12, 371-384.
237. Tournier-Lasserve E, Joutel A, Melki J, Weissenbach J, Lathrop GM, Chabriat H, Mas JL, Cabanis EA, Baudrimont M, Maciazek J, Bach MA, Bousser MG (1993) Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy maps to chromosome 19q12. Nat Genet 3, 256-259.
238. Joutel A, Corpechot C, Ducros A, Vahedi K, Chabriat H, Mouton P, Alamowitch S, Domenga V, Cecillion M, Marechal E, Maciazek J, Vayssiere C, Cruaud C, Cabanis EA, Ruchoux MM, Weissenbach J, Bach JF, Bousser MG, Tournier-Lasserve E (1996) Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature 383, 707-710.
239. Wang W, Prince CZ, Mou Y, Pollman MJ (2002) Notch3 signaling in vascular smooth muscle cells induces c-FLIP expression via ERK/MAPK activation. Resistance to Fas ligand-induced apoptosis. J Biol Chem 277, 21723-21729.
240. Wang T, Baron M, Trump D (2008) An overview of Notch3 function in vascular smooth muscle cells. Prog Biophys Mol Biol 96, 499-509.
241. Formichi P, Radi E, Battisti C, Di Maio G, Tarquini E, Leonini A, Di Stefano A, Dotti MT, Federico A (2009) Apoptosis in CADASIL: An in vitro study of lymphocytes and fibroblasts from a cohort of Italian patients. J Cell Physiol 219, 494-502.
242. Viswanathan A, Gray F, Bousser MG, Baudrimont M, Chabriat H (2006) Cortical neuronal apoptosis in CADASIL. Stroke 37, 2690-2695.
243. Battisti C, Formichi P, Radi E, Malandrini A, Federico A (2009) Evaluation of brain apoptosis in a CADASIL postmortem case. Clin Neuropathol 28, 358-361.